本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Vera Therapeutics, Inc.

31.77
-1.9000-5.64%
盤後31.60-0.1700-0.54%18:50 EDT
成交量:391.09萬
成交額:1.25億
市值:22.78億
市盈率:-5.39
高:34.00
開:33.22
低:31.19
收:33.67
52周最高:56.05
52周最低:23.05
股本:7,171.39萬
流通股本:5,239.41萬
量比:1.03
換手率:7.46%
股息:- -
股息率:- -
每股收益(TTM):-5.8984
每股收益(LYR):-4.6644
淨資產收益率:-91.75%
總資產收益率:-46.76%
市淨率:5.59
市盈率(LYR):-6.81

資料載入中...

2026/09/15

重要事件披露

Form 8-K - Current report
2026/09/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/11

重要事件披露

Form 8-K - Current report
2026/08/07

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/30

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/09

重要事件披露

Form 8-K - Current report
2026/07/07

重要事件披露

Form 8-K - Current report
2026/06/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/02

重要事件披露

Form 8-K - Current report
2026/05/27

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/07

重要事件披露

Form 8-K - Current report
2026/04/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/01

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/09

重要事件披露

Form 8-K - Current report
2026/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans